Skip to main content

Advertisement

Log in

Antiretroviral Therapy and Pregnancy: Effect on Cortical Bone Status of Human Immunodeficiency Virus–Infected Caucasian Women as Assessed by Quantitative Ultrasonography

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Treatment with antiretroviral agents (ARVs) during pregnancy is important to prevent mother-to-child transmission of the human immunodeficiency virus (HIV), but their use has been associated with low bone mineral density in adult patients. Currently, there are no data regarding the bone status of HIV-infected women who received ARV during pregnancy. The aim of this study was to evaluate cortical bone status at delivery in a group of HIV-infected women who received ARV during pregnancy and to monitor the changes occurring during the first year postpartum. We studied 33 HIV-infected and 116 HIV-uninfected healthy Caucasian women within 4 days from delivery. Follow-up measurements were performed at 4 and 12 months postpartum in 17 HIV-infected and 55 healthy women. Cortical bone status was evaluated by quantitative ultrasonography at the mid-tibia, and bone measurements were expressed as the speed of sound (SOS). HIV-infected women after delivery had a median SOS of 3,985 (3,567–4,242) m/s, while the median SOS of healthy women was 4,025 (3,643–4,250) m/s. The difference was not significant (t = 0.39, P = 0.69). No significant differences were observed between ARV-exposed and control subjects at 4 and 12 months. Our data suggest that ARV during pregnancy and the first year after delivery does not affect negatively cortical bone status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. European Collaborative Study (2006) The mother-to-child HIV transmission epidemic in Europe: evolving in the east and established in the west. AIDS 20:1419–1427

    Article  Google Scholar 

  2. Fowler MG, Lampe MA, Jamieson DJ, Kourtis AP, Rogers MF (2007) Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions. Am J Obstet Gynecol 197:S3–S9

    Article  PubMed  Google Scholar 

  3. Brown TT, Qaqish RB (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20:2165–2174

    Article  PubMed  Google Scholar 

  4. van Vonderen MG, Lips P, van Agtmael MA, Hassink EA, Brinkman K, Geerlings SE et al (2009) First line zidovudine/lamivudine/lopinavir/ ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ ritonavir. AIDS 23:1367–1376

    Article  PubMed  Google Scholar 

  5. Gallant JE, DeJesus E, Arribas JR et al (2006) Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N Engl J Med 354:251–260

    Article  PubMed  CAS  Google Scholar 

  6. Stellbrink HJ, Orkin C, Arribas JR et al (2010) Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. Clin Infect Dis 51:963–972

    Article  PubMed  Google Scholar 

  7. Brown TT, McComsey GA, King MS, Qaqish RB, Bernstein BM, da Silva BA (2009) Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. J Acquir Immune Defic Syndr 51:554–561

    Article  PubMed  CAS  Google Scholar 

  8. Duvivier C, Kolta S, Assoumou L et al (2009) Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients. AIDS 27:817–824

    Article  Google Scholar 

  9. McComsey GA, lo Re V, O’Riordan M et al (2008) Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study. Clin Infect Dis 46:1290–1296

    Article  PubMed  CAS  Google Scholar 

  10. Kolthoff N, Eiken P, Kristensen B, Nielsen SP (1998) Bone mineral changes during pregnancy and lactation: a longitudinal cohort study. Clin Sci (Lond) 94:405–412

    CAS  Google Scholar 

  11. Ritchie LD, Fung EB, Halloran PB et al (1998) A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am J Clin Nutr 67:693–701

    PubMed  CAS  Google Scholar 

  12. Naylor KE, Iqbal P, Fledelius C, Fraise RB, Eastell R (2000) The effect of pregnancy on bone density and bone turnover. J Bone Miner Res 15:129–136

    Article  PubMed  CAS  Google Scholar 

  13. Laskey MA, Price RI, Khoo BCC, Prentice A (2011) Proximal femur structural geometry changes during and following lactation. Bone 48:755–759

    Article  PubMed  CAS  Google Scholar 

  14. Costa ML, Krupa FG, Rheder PM, Sousa MH, Costa-Paiva L, Cecatti JG (2012) Forearm bone mineral density changes during postpartum and the effects of breastfeeding, amenorrhea, body mass index and contraceptive use. Osteoporos Int 23:1691–1698

    Article  PubMed  CAS  Google Scholar 

  15. Møller UK, Viŏ Streym S, Mosekilde L, Rejnmark L (2012) Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled study. Osteoporos Int 23:1213–1223

    Article  PubMed  Google Scholar 

  16. Kraemer B, Schneider S, Rothmund R, Fehm T, Wallwiener D, Solomayer E-F (2012) Influence of pregnancy on bone density: a risk factor for osteoporosis? Measurements of the calcaneus by ultrasonometry. Arch Gynecol Obstet 285:907–912

    Article  PubMed  Google Scholar 

  17. Lee SC, Coan BS, Bouxsein ML (1997) Tibial ultrasound velocity measured in situ predicts the material properties of tibial cortical bone. Bone 21:119–125

    Article  PubMed  CAS  Google Scholar 

  18. Nguyen TV, Center JR, Eisman JA (2004) Bone mineral density–independent association of quantitative ultrasound measurements and fracture risk in women. Osteoporos Int 15:942–947

    Article  PubMed  Google Scholar 

  19. Kovacs CS (2011) Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol Metab Clin North Am 40:795–826

    Article  PubMed  CAS  Google Scholar 

  20. Zuccotti G, Viganò A, Gabiano C et al (2010) Antiretroviral therapy and bone mineral measurements in HIV-infected youths. Bone 46:1633–1638

    Article  PubMed  Google Scholar 

  21. Haskelberg H, Hoy JF, Amin J, Ebeling PR, Emery S, Carr A, STEAL Study Group (2012) Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine. PLoS One 7:e38377

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported in part by Grant “Bando nazionale AIDS 2009” (number 40H1).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefano Mora.

Additional information

The authors have stated that they have no conflict of interest.

Stefano Mora and Cecilia Diceglie contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mora, S., Diceglie, C., Viganò, A. et al. Antiretroviral Therapy and Pregnancy: Effect on Cortical Bone Status of Human Immunodeficiency Virus–Infected Caucasian Women as Assessed by Quantitative Ultrasonography. Calcif Tissue Int 92, 394–398 (2013). https://doi.org/10.1007/s00223-013-9696-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-013-9696-8

Keywords

Navigation